| Active ingredient (INN) | Amikacin Sulfate |
|---|---|
| ATC level 5 | D06AX12 |
| ATC level 4 | D06AX |
| Therapeutic category | Auto-created by FDA Drug Enforcement — Full Recall Database scraper |
| Controlled substance |
|---|
| No |
| Marketing-authorisation holders | HIKMA PHARMACEUTICALS USA INC., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., SANDOZ CANADA INCORPORATED, OMEGA LABORATORIES LIMITED |
|---|
| Registrations on file | 5 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Amikacin Sulfate | 250mg/mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Amikacin Sulfate | 500mg/2mL | injection | 🇺🇸 US | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Active |
| Amikacin Sulfate | 1g/4mL | injection | 🇺🇸 US | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Active |
| Amikacin Sulfate Injection Usp | — | liquid | 🇨🇦 CA | SANDOZ CANADA INCORPORATED | Active |
| AMIKACIN SULFATE INJECTION | — | solution | 🇨🇦 CA | OMEGA LABORATORIES LIMITED | Active |